Cell Therapeutics plans spin-off
NEW YORK, Feb 12 (Reuters) - Cell Therapeutics Inc. (CTIC.O) said on Monday it plans to form a spin-off company to focus on a technology that it created to speed up the development of new treatments.
Aequus BioPharma will use the company's Genetic Polymer technology to extend the plasma half-life of therapeutic proteins, which Cell Therapeutics said it hopes will lower the cost for developing next-generation biologics, such as chemotherapy-related treatment Neulasta or anemia drug Aranesp.
((Reporting by Christopher Kaufman, editing by John Wallace; New York Equities Desk; +1 646 223 6044)) Keywords: CELLTHERAPEUTICS/
(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWEN4095










